Human herpesvirus-6 in transplantation: An emerging pathogen

Annals of Internal Medicine

Volumn 124, Issue 12, 1996, Pages 1065-1071

  Singh, Nina ^a   Carrigan, Donald R ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 [4 HYDROXY 2 (HYDROXYMETHYL)BUTYL]GUANINE; ACICLOVIR; AMPLIGEN; CYTOKINE; FOSCARNET; GANCICLOVIR; GUANOSINE DERIVATIVE;

APLASTIC ANEMIA; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNODEFICIENCY; CLINICAL FEATURE; DRUG SENSITIVITY; ENCEPHALITIS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; REVIEW; SUPERINFECTION; VIRUS DETECTION; VIRUS PATHOGENESIS;

ANTIVIRAL AGENTS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; OPPORTUNISTIC INFECTIONS; TRANSPLANTATION IMMUNOLOGY;

EID: 0030317625     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-12-199606150-00007     Document Type: Article

References (58)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferate disorders. Science. 1986;:234:596-601.
2. Ablashi DV, Salahuddin SZ, Josephs SF, Imam F, Lusso P, Gallo RC, et al. HBLV (or HHV-6) in human cell lines [Letter]. Nature. 1987;329:207.
3. Krueger GR, Klueppelberg U, Hoffman A, Ablashi DV. Clinical correlates of infection with human herpesvirus-6. In Vivo. 1994;8:457-85.
4. Lawrence GL, Chee M, Craxton MA, Gompels UA, Honess RW, Barrell BG. Human herpesvirus 6 is closely related to human cytomegalovirus. J Virol. 1990;64:287-99.
5. Russler SK, Tapper MA, Carrigan DR. Susceptibility of human herpesvirus 6 to acylovir and ganciclovir [Letter]. Lancet. 1989;2:382.
6. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988;1:1065-7.
7. Yoshikawa T, Nakashima T, Suga S, Asano Y, Yazaki T, Kimura H, et al. Human herpesvirus-6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningoencephalitis. Pediatrics. 1992:89(5 Pt 1):888-90.
8. McCullers JA, Lakeman FD, Whitley RJ. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis. 1996;21:571-6.
9. Agut H. Puzzles concerning the pathogenicity of human herpesvirus 6 [Editorial]. N Engl J Med. 1993;329:203-4.
10. Knox KK, Carrigan DR. Disseminated active HHV-6 infections in patients with AIDS. Lancet. 1994;343:577-8.
11. Lusso P, Gallo RC. Human herpesvirus 6 in AIDS. Immunol Today. 1995;16:67-71.
12. Knox KK, Carrigan DR. Active human herpesvirus (HHV-6) infection of central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retroviral. 1995;9:69-73.
13. Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis. 1993;167:735-9.
14. Drobyski WR, Eberle M, Majewski D, Baxter-Lowe LA. Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. J Clin Microbiol. 1993;31:1515-20.
15. Jacobs U, Ferber J, Klehr HU. Severe allograft dysfunction after OKT3-induced human herpes virus-6 reactivation. Transplant Proc. 1994;26:3121
16. Okuno T, Higashi K, Shiraki K, Yamanishi K, Takahashi M, Kokado Y, et al. Human herpesvirus 6 infection in renal transplantation. Transplantation. 1990;49:519-22.
17. Morris DJ, Littler E, Arrand JR, Jordan D, Mallick NP, Johnson RW. Human herpesvirus 6 infection in renal-transplant recipients [Letter] N Engl J Med. 1989;320:1560-1.
18. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yazaki T, Ono Y, et al. A prospective study of human herpesvirus-6 infection in renal transplantation. Transplantation. 1992;54:879-83.
19. Singh N, Carrigan DR, Gayowski T, Singh J, Marino IR. Variant B human herpesvirus-6 associated febrile dermatosis witih thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation. 1995;60:1355-7.
20. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief Report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med. 1994;330:1356-60.
21. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yazaki T, Sobue R, et al. Human herpesvirus-6 infection in bone marow transplantation. Blood. 1991;78:1381-4.
22. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet. 1991;338:147-9.
23. Cone RW, Hackman RC, Huang ML, Bowden RA, Myers JD, Metcalf M, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med. 1993;329:156-61.
24. Okuno T, Takahashi K, Balachandra K, Shiraki K, Yamanishi K, Takahashi M, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol. 1989;27:651-3.
25. Jarrett RF, Clark DA, Josephs SF, Onions DE. Detection of human herpesvirus-6 DNA in peripheral blood and saliva. J Med Virol. 1990;32:73-6.
26. Frenkel N, Katsafanas GC, Wyatt LS, Yoshikawa T, Asano Y. Bone marrow transplant recipients harbor the B variant of human herpesvirus 6. Bone Marrow Transplant. 1994;14:839-43.
27. Rosenfeld CS, Rybka WB, Weinbaum D, Carrigan DR, Knox KK, Andrews DF, et al. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol. 1995;23:626-9.
28. Carrigan DR, Knox KK. Bone marrow suppression by human herpesvirus-6: comparison of the A and B variant of the virus [Letter]. Blood. 1995;86:835-6.
29. Lusso P, Malnati M, De Maria A, Balotta C, DeRocco SE, Markham PD, et al. Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol. 1991;147:685-91.
30. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood. 1995;85:1263-71.
31. Knox KK, Carrigan DR. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J Infect Dis. 1992;165:925-9.
32. Burd EM, Knox KK, Carrigan DR. Human herpesvirus-6-associated suppression of growth factor-induced macrophage maturation in human bone marrow cultures. Blood. 1993;81:1545-50.
33. Horvat RT, Parmely MJ, Chandran B. Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells. J Infect Dis. 1993;167:1274-80.
34. Knox KK, Pietryga D, Harrington DJ, Franciosi R, Carrigan DR. Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant. Clin Infect Dis. 1995;20:406-13.
35. Schonnebeck M, Krueger GR, Braun M, Fischer M, Koch B, Ablashi DV, et al. Human herpesvirus-6 infection may predispose cells to superinfection by other viruses. In Vivo. 1991;5:255-63.
36. Cone RW, Huang ML, Hackman RC. Human herpesvirus 6 and pneumonia. Leuk Lymphoma. 1994;15:235-41.
37. Flamand L, Stefanescu I, Ablashi DV, Menezes J. Activation of Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol. 1993;67:6768-77.
38. Carrigan DR. Human herpesvirus after bone marrow transplantation. In: Ablashi DV, Krueger GR, Salahuddin DZ, eds. Human herpesvirus-6: epidemiology, molecular biology, and clinical pathology, v 4. New York: Elsevier; 1992:281-301.
39. Carrigan DR, Knox KK. Human herpesvirus-6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood. 1994;84:3307-10.
40. Wilborn F, Brinkmann V, Schmidt CA, Neipel F, Gelderblom H, Siegert W. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood. 1994;83:3052-8.
41. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis. 1995;171:273-80.
42. Chou SW, Scott KM. Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant patients with primary cytomegalovirus infection. J Clin Microbiol. 1990;28:851-4.
43. Carrigan DR. Human herpesvirus-6 and bone marrow transplantation [Letter]. Blood. 1995;85:294-5.
44. Carrigan DR, Milburn G, Dienglewicz R, Kernen N, Papadopoulas E, Singh N. Diagnosis of active human herpesvirus six (HHV-6) infections in immunosuppression and patients with a rapid shell-vial assay [Abstract]. In: Abstracts of the 96th General Meeting of the American Society for Microbiology. New Orleans: Amer Soc Microbiol; 1996.
45. Pitalia AK, Liu-Yin JA, Freemont AJ, Morris DJ, Fitzmaurice RJ. Immunohistological detection of human herpes virus 6 in formalin-fixed, paraffin-embedded lung tissues. J Med Virol. 1993;41:103-7.
46. Knox KK, Carrigan DR. Active human herpesvirus-6 infection in the lymph nodes of HIV infected patients: in vitro evidence that human herpesvirus-6 can break HIV latency. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:370-8.
47. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolf P, Obert G. Longitudinal study of human herpesvirus-6 infection in organ transplant recipients. Clin Infect Dis. 1996;22:171-3.
48. Ward KN, Gray JJ, Efstathiou S. Primary human herepesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol. 1989;28:67-72.
49. Knox KK, Carrigan DR. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus-6 in a bone marrow transplant recipient. Clin Infect Dis. 1996;22:174-5.
50. Knox KK, Carrigan DR. HHV-6 and CMV pneumonitis in immunocompromised pateints [Letter]. Lancet. 1994;343:1647.
51. Asano Y, Yoshikawa T, Kajita Y, Ogura R, Suga S, Yazaki T, et al. Fatal encephalitits/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child. 1992;67:1484-5.
52. Pruksananonda P, Hall CB, Insel RA, McIntyre K, Pellet PE, Long CE, et al. Primary human herpevirus 6 infection in young children. N Engl J Med. 1992;326:1445-50.
53. Streicher HZ, Hung CL, Ablashi DV, Hellman K, Saxinger C, Fullen J, et al. In vitro inhibtion of human herpesvirus-6 by phosphonoformate. J Virol Methods. 1988;21:301-4.
54. Agut H, Aubin JT, Huraux JM. Homogenous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro [Letter]. J Infect Dis. 1991;163:1382-3.
55. Shiraki K, Okuno T, Yamanishi K, Takahashi M. Phosphonoacetic acid inhibits replication of human herpesvirus-6. Antiviral Res. 1989;12:311-8.
56. Burns WH, Sandford GR. Susceptibility of human herpesvirus 6 to antivirals in vitro. J Infect Dis. 1990;152:634-7.
57. Akesson-Johasson A, Harmenberg J, Wahren B, Linde A. Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. Antimicrob Agents Chemother. 1990;34:2417-9.
58. Ablashi DV, Berneman ZN, Lawyer C, Kramarsky B, Ferguson DM, Komaroff AL. Antiviral activity in vitro of Kutapressin against human herpesvirus-6. In Vivo. 1994;8:581-6.